Polymorphonuclear leucocytes have two opposing roles in fibrinolysisTHROMBOSIS AND HAEMOSTASISIF4.32017-12-0826PREAI
Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysisJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52010-09-0161OAAI
Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by plateletsJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52010-06-0128OAAI
Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysisJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52010-06-0120OAAI
The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitroBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2921OAAI
Bispecific targeting of thrombin activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 by a heterodimer diabodyJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52008-11-0118OAAI
TAFIa, PAI-1 and α2-antiplasmin:: complementary roles in regulating lysis of thrombi and plasma clotsJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52007-04-01113OAAI
Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFIJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52003-09-0154OAAI
Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot studyACTA DIABETOLOGICAIF2.91999-12-0113PREAI